Results 21 to 30 of about 2,447 (165)

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

open access: yesArquivos de Neuro-Psiquiatria
Transthyretin familial amyloid polyneuropathy is an autosomal dominant inherited sensorimotor and autonomic polyneuropathy, which if untreated, leads to death in approximately 10 years.
Marcus Vinicius Pinto   +11 more
doaj   +1 more source

Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil

open access: yesArquivos de Neuro-Psiquiatria
Background Tafamidis is a kinetic stabilizer that binds to the transthyretin (TTR) gene, inhibiting its dissociation. It is the only disease-modifying treatment for hereditary TTR amyloidosis with peripheral neuropathy (ATTRv-PN) available in ...
Luiz Felipe Pinto   +9 more
doaj   +1 more source

Amyloid neuropathy in multiple myeloma and other plasma cell dyscrasias : a hypothesis of the pathogenesis of amyloid neuropathies

open access: yes, 1983
The development of amyloid neuropathy is an uncommon complication of multiple myeloma. The clinical, electrophysiological and pathological features of 3 such patients are described.
K. P. McAdam   +7 more
core   +1 more source

Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS)

open access: yesArquivos de Neuro-Psiquiatria
Transthyretin amyloidosis (ATTR) is characterized by the deposit of mutant or wild-type transthyretin that forms amyloid fibrils, which are extracellularly deposited within tissues and organs.
Márcia Waddington Cruz   +9 more
doaj   +1 more source

Charcot-Marie-Tooth disease and other inherited neuropathies

open access: yes, 2014
Inherited peripheral neuropathies are among the most common genetic neuromuscular disorders worldwide. However, their diagnosis can be challenging due to genotypic and phenotypic variability.
Saporta, Mario A
core   +1 more source

Late-onset familial amyloidosis polyneuropathy associated with c.186G>C in transthyretin

open access: yesRevista de la Facultad de Ciencias Médicas de Córdoba
Introduction: The most common form of hereditary amyloidosis is associated with variants of transthyretin (TTR). Familial amyloidosis polyneuropathy associated with variants of TTR (FAP-TTR) is an infrequent, multisystemic disease, with predominant ...
Eugenia Conti   +3 more
doaj   +1 more source

Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy

open access: yes, 2012
Objective: Familial amyloid polyneuropathy (FAP) is an autosomal dominant form of hereditary amyloidosis. Several studies reported coagulation factor X deficiency and excessive fibrinolysis in immunoglobulin light chain amyloidosis.
10345613   +24 more
core   +1 more source

Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).

open access: yes, 2007
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal dominant neuropathies of fatal outcome within 10 years after inaugural symptoms.
Planté-Bordeneuve, Violaine   +6 more
core   +1 more source

Characterization of Patients with Hereditary Transthyretin Amyloid Polyneuropathy Using Quantitative Sensory Testing at an Electrophysiological Research Center in Bogotá

open access: yes, 2023
ilustracionesCaracterización de Pacientes con Polineuropatía Amiloidótica Hereditaria por Transtiretina, Usando la Prueba Cuantitativa Sensitiva en un Centro de Investigación Electrofisiológica en la Ciudad de Bogotá Introducción: La amiloidosis ...
Lasso Benavides, Jairo Fernando
core   +1 more source

Variable presentations of TTR familial amyloid polyneuropathy in seventeen patients.

open access: yes, 2011
Autosomal-dominant transthyretin (TTR)-related amyloidosis usually manifests in the second to fourth decade with a length-dependent axonal neuropathy with prominent involvement of the small fibers and multi-organ systemic failure.
FERRARI S   +31 more
core   +1 more source

Home - About - Disclaimer - Privacy